Search results
Results from the WOW.Com Content Network
Kennedy has long railed against vaccines, once calling those that protect against Covid-19 a "crime against humanity." He has treaded more carefully in recent weeks, though, and has said he wouldn ...
Trump said during a rally in late October that he would let Kennedy “go wild” on healthcare in the country, and vaccine stocks like Moderna and Novavax have been heading lower since. Thursday ...
An hour before the market closed Thursday, as news reports of Trump’s choice began trickling out, Covid-19 vaccine maker Moderna dipped as much as 6%, ... Pfizer stock has dipped 11%, and ...
Stocks of coronavirus vaccine could run out at the end of January unless new ones such as the Oxford jab are approved, a former minister has warned. Former health secretary Jeremy Hunt told the ...
Novavax successfully developed a COVID-19 vaccine that is currently its only product on the market. The company has been working on two other candidates. One is an investigational influenza vaccine.
As people acclimatize to the new normal, it’s time to look at some vaccine stocks to sell. Instead of relying primarily on vaccines and antiviral drugs, the government let people manage infections.
Novavax (NASDAQ:NVAX) saw its shares rise yesterday amid positive social media momentum, but they have been just as quick to fall today due to bad news. Negative delivery statistics have pushed ...
It went from just over $21 per share in March 2020 to more than $321 per share in October 2021. However, the stock has done poorly more recently — shares are up 0.88% overall for the year, but ...